APA (7th ed.) Citation

Lugen, B., Dmitrieva, M. V., Orlova, O. L., Krasnyuk, I. I., (jr.), I. I. K., Bokov, D. O., . . . Belyackaya, A. V. (2020). Development of a Liposomal Dosage Form Based on Hydrophobic Derivative of Indolocarbazole. LLC Center of Pharmaceutical Analytics (LLC «CPHA»).

Chicago Style (17th ed.) Citation

Lugen, B., M. V. Dmitrieva, O. L. Orlova, I. I. Krasnyuk, I. I. Krasnyuk (jr.), D. O. Bokov, O. I. Stepanova, and A. V. Belyackaya. Development of a Liposomal Dosage Form Based on Hydrophobic Derivative of Indolocarbazole. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020.

MLA (9th ed.) Citation

Lugen, B., et al. Development of a Liposomal Dosage Form Based on Hydrophobic Derivative of Indolocarbazole. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2020.